Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
Condition(s):Tuberous Sclerosis ComplexLast Updated:February 8, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Tuberous Sclerosis ComplexLast Updated:February 8, 2024Recruiting
Condition(s):Tuberous Sclerosis ComplexLast Updated:February 14, 2024Active, not recruiting
Condition(s):Tuberous Sclerosis ComplexLast Updated:March 10, 2020Unknown status
Condition(s):Tuberous SclerosisLast Updated:November 6, 2020Unknown status
Condition(s):Tuberous SclerosisLast Updated:January 30, 2018Unknown status
Condition(s):Tuberous Sclerosis ComplexLast Updated:May 4, 2017Completed
Condition(s):Tuberous Sclerosis ComplexLast Updated:February 4, 2021Completed
Condition(s):Tuberous Sclerosis Complex Associated Neuropsychiatric DiseaseLast Updated:March 19, 2024Recruiting
Condition(s):Tuberous Sclerosis ComplexLast Updated:May 2, 2018Completed
Condition(s):Tuberous Sclerosis ComplexLast Updated:January 25, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.